Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
GSK, Teva quietly settle Coreg 'skinny label' dispute
Following a more than decade-long legal back-and-forth over the practice known as “skinny” labeling, GSK and Teva have put their dispute to bed.
Fraiser Kansteiner
Feb 11, 2026 11:40am
Teva's growth will likely slow in 2026, company warns
Jan 28, 2026 11:20am
Biosimilar execs optimistic about future for US biosims
Jan 22, 2026 12:56pm
Partners Alvotech, Teva eye 2026 Eylea biosimilar launch
Dec 19, 2025 10:40am
Antheia links with TAPI to scale biosynthetic drug ingredients
Nov 20, 2025 8:00am
Teva debuts innovation platform to parry key industry challenges
Nov 19, 2025 8:38am
